Optimizing Cotreatment of HCV and HIV Infection

All PLWH who are coinfected with HCV should be offered curative HCV treatment. Nonadherence to ART or a lack of HIV suppression should not affect candidacy for treatment of HCV.

Mark S. Sulkowski, MD Released: November 8, 2018

Managing people living with both HIV and HCV and polypharmacy can be difficult. How do you analyze which HCV regimen to use and identify relevant drug interactions?

Annie Luetkemeyer, MD Released: December 12, 2018

Treatment of HCV/HIV coinfection requires continued awareness of and attention to the complex drug–drug interactions that can occur, especially when using pharmacologically boosted ARVs and nonnucleoside reverse transcriptase inhibitors. Here’s my take on how to approach drug–drug interactions using patient cases.

Susanna Naggie, MD, MHS Released: January 25, 2019